Cite
Eggert T, McGlynn KA, Duffy A, et al. Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database. United European Gastroenterol J. 2013;1(5):351-7doi: 10.1177/2050640613501507.
Eggert, T., McGlynn, K. A., Duffy, A., Manns, M. P., Greten, T. F., & Altekruse, S. F. (2013). Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database. United European gastroenterology journal, 1(5), 351-7. https://doi.org/10.1177/2050640613501507
Eggert, Tobias, et al. "Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database." United European gastroenterology journal vol. 1,5 (2013): 351-7. doi: https://doi.org/10.1177/2050640613501507
Eggert T, McGlynn KA, Duffy A, Manns MP, Greten TF, Altekruse SF. Fibrolamellar hepatocellular carcinoma in the USA, 2000-2010: A detailed report on frequency, treatment and outcome based on the Surveillance, Epidemiology, and End Results database. United European Gastroenterol J. 2013 Oct;1(5):351-7. doi: 10.1177/2050640613501507. PMID: 24917983; PMCID: PMC4040774.
Copy
Download .nbib